Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 23Neoplasm Metastasis 7Brain Neoplasms 5Prostatic Neoplasms 4Oligodendroglioma 2Neoplasms 2Glioma 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Venous Thromboembolism 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Unilateral Breast Neoplasms 1Spinal Cord Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Ovarian Neoplasms 1Neoplasms by Site 1Meningioma 1Malignant Neoplasms of Female Genital Organs 1Lung Neoplasms 1Liposarcoma 1Glioblastoma 1Gastro-enteropancreatic neuroendocrine tumor 1Ependymoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiovascular Diseases 1

Interventions

Cyclophosphamide 5regorafenib 3Temozolomide 3Magnetic Resonance Spectroscopy 3Irinotecan 3Etoposide 3Doxorubicin 3ulixertinib 2tipifarnib 2selpercatinib 2palbociclib 2ivosidenib 2etoposide phosphate 2cabozantinib 2X-Rays 2Vincristine 2Specimen Handling 2Sirolimus 2Radiation 2Phantoms, Imaging 2Nuclear Medicine Department, Hospital 2Ifosfamide 2Biopsy 2tazemetostat 1racemetyrosine 1pembrolizumab 1olaparib 1larotrectinib 1ganitumab 1erdafitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Sarcoma, Ewing × abemaciclib × Clear all
NCT05440786 2026-04-13

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

Eli Lilly and Company

Phase 2 Active not recruiting
46 enrolled 19 charts
Sarcoma

Neoplasm Metastasis, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡